We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Justin Ryder PhD

Justin R. Ryder PhD

Assistant Professor of Pediatrics and Associate Director of Research, Center for Pediatric Obesity Medicine, University of Minnesota Medical School, Minneapolis, Minnesota

Justin Ryder, PhD, is an Assistant Professor of Pediatrics at the University of Minnesota Medical Center and Associate Director of Research for the Center for Pediatric Obesity Medicine. Dr. Ryder is a clinical translational pediatric obesity researcher focused on understanding the intersection between obesity and chronic disease risk. His research program studies the short- and long-term impact pediatric obesity has on numerous organ systems with a primary goal of integrating state-of-the-art techniques in these populations in order to expedite our understanding of the health consequences of obesity. To this end, he leads a diverse research program with studies that range from observational to longitudinal cohort studies to novel treatments all aimed to improve the lives of children today and in the future who struggle with obesity. The interventional treatment studies are designed to target specific chronic diseases, particularly fatty liver and cardiovascular disease, using novel, biology-based treatments (e.g. pharmacotherapy and bariatric surgery). The ultimate goal is to provide children with better treatments for the disease of obesity and often co-morbid disease conditions which impact their daily lives and long term health.


Dr. Ryder receives a donation of drug and placebo for a clinical trial from Boehringer Ingelheim.